{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:49:16Z","timestamp":1788184156940,"version":"build-2803163510"},"reference-count":20,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2023,1,25]]},"DOI":"10.1253\/circj.cj-22-0168","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T22:11:28Z","timestamp":1663107088000},"page":"360-367","source":"Crossref","is-referenced-by-count":6,"title":["Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease\u3000\u2015 An Observation From the REAL-CAD Study \u2015"],"prefix":"10.1253","volume":"87","author":[{"given":"Toshiaki","family":"Toyota","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Hyogo College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iimuro","sequence":"additional","affiliation":[{"name":"Innovation and Research Support Center, International University of Health and Welfare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Retsu","family":"Fujita","sequence":"additional","affiliation":[{"name":"Innovation and Research Support Center, International University of Health and Welfare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Dokkyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nishihata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, St. Luke\u2019s International Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Suwa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Caress Sapporo Hokko Memorial Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shiomi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naritatsu","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Natsuaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Integrated Science and Technology for Sustainable Society, Chuo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masunori","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"St. Hill Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, et al. High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): A randomized superiority trial. <i>Circulation<\/i> 2018; 137: 1997\u20132009.","DOI":"10.1161\/CIRCULATIONAHA.117.032615"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. <i>N Engl J Med<\/i> 2005; 352: 1425\u20131435.","DOI":"10.1056\/NEJMoa050461"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2014; 63: 2889\u20132934.","DOI":"10.1161\/01.cir.0000437738.63853.7a"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2019; 73: 3168\u20133209.","DOI":"10.1161\/CIR.0000000000000624"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. <i>Eur Heart J<\/i> 2020; 41: 111\u2013188.","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P, Pedersen TR, et al. Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials. <i>J Am Coll Cardiol<\/i> 2014; 64: 485\u2013494.","DOI":"10.1016\/j.jacc.2014.02.615"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, et al. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2. <i>Circ J<\/i> 2012; 76: 1369\u20131379.","DOI":"10.1253\/circj.CJ-11-1356"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Leibowitz M, Karpati T, Cohen-Stavi CJ, Feldman BS, Hoshen M, Bitterman H, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic heart disease taking statin treatment. <i>JAMA Intern Med<\/i> 2016; 176: 1105\u20131113.","DOI":"10.1001\/jamainternmed.2016.2751"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). <i>JAMA<\/i> 2001; 285: 2486\u20132497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. <i>Circulation<\/i> 2004; 110: 227\u2013239.","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"11","unstructured":"11. European Association for Cardiovascular Prevention &amp; Rehabilitation; Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC\/EAS guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). <i>Eur Heart J<\/i> 2011; 32: 1769\u20131818."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. <i>N Engl J Med<\/i> 1999; 341: 70\u201376.","DOI":"10.1056\/NEJM199907083410202"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial. <i>JAMA<\/i> 2001; 285: 1711\u20131718.","DOI":"10.1001\/jama.285.13.1711"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. <i>J Am Coll Cardiol<\/i> 2009; 54: 558\u2013565.","DOI":"10.1016\/j.jacc.2009.05.028"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. <i>N Engl J Med<\/i> 2017; 376: 1713\u20131722.","DOI":"10.1056\/NEJMoa1615664"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. <i>N Engl J Med<\/i> 2018; 379: 2097\u20132107.","DOI":"10.1056\/NEJMoa1801174"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. <i>N Engl J Med<\/i> 2015; 372: 2387\u20132397.","DOI":"10.1056\/NEJMoa1410489"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Koskinas KC, Siontis GCM, Piccolo R, Mavridis D, Raber L, Mach F, et al. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: A meta-analysis of randomized trials. <i>Eur Heart J<\/i> 2018; 39: 1172\u20131180.","DOI":"10.1093\/eurheartj\/ehx566"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. O\u2019Keefe JH Jr, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg\/dl: Lower is better and physiologically normal. <i>J Am Coll Cardiol<\/i> 2004; 43: 2142\u20132146.","DOI":"10.1016\/j.jacc.2004.03.046"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cholesterol Treatment Trialists\u2019 (CTT) Collaboration; Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. <i>Lancet<\/i> 2010; 376: 1670\u20131681.","DOI":"10.1016\/S0140-6736(10)61350-5"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/2\/87_CJ-22-0168\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T03:25:42Z","timestamp":1674876342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/2\/87_CJ-22-0168\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-22-0168","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"article-number":"CJ-22-0168"}}